|
gptkbp:instanceOf
|
vaccine
|
|
gptkbp:alsoKnownAs
|
gptkb:Johnson_&_Johnson_COVID-19_vaccine
gptkb:Ad26.COV2.S
|
|
gptkbp:approvalYear
|
2021-02-27 (US EUA)
|
|
gptkbp:category
|
gptkb:COVID-19_pandemic
gptkb:Johnson_&_Johnson_brands
Vaccines approved by the European Medicines Agency
|
|
gptkbp:clinicalTrialPhase
|
gptkb:ENSEMBLE_trial
|
|
gptkbp:contains
|
recombinant, replication-incompetent adenovirus type 26 expressing SARS-CoV-2 spike protein
|
|
gptkbp:countryOfOrigin
|
gptkb:United_States
|
|
gptkbp:developedBy
|
gptkb:Johnson_&_Johnson
gptkb:Janssen_Pharmaceuticals
|
|
gptkbp:dosesRequired
|
1
|
|
gptkbp:efficacyAgainstModerateToSevereCOVID19
|
66%
|
|
gptkbp:efficacyAgainstSevereCOVID19
|
85%
|
|
gptkbp:emergencyServices
|
gptkb:European_Union
gptkb:United_States
gptkb:World_Health_Organization
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Janssen COVID-19 vaccine
|
|
gptkbp:manufacturer
|
gptkb:Emergent_BioSolutions
gptkb:Biological_E._Limited
gptkb:Janssen_Biologics
gptkb:Reig_Jofre
gptkb:Catalent
gptkb:IDT_Biologika
|
|
gptkbp:notRecommendedFor
|
people with history of severe allergic reaction to vaccine ingredients
children under 18 (initially)
|
|
gptkbp:rareAdverseEvent
|
gptkb:Guillain-Barré_syndrome
thrombosis with thrombocytopenia syndrome
|
|
gptkbp:retired
|
availability of alternative vaccines
risk of rare blood clots
|
|
gptkbp:routeOfAdministration
|
intramuscular injection
|
|
gptkbp:shelfLife
|
2 years (frozen)
3 months (refrigerated)
|
|
gptkbp:sideEffect
|
fever
fatigue
headache
muscle pain
pain at injection site
|
|
gptkbp:storage
|
2–8°C
|
|
gptkbp:target
|
gptkb:COVID-19
|
|
gptkbp:technology
|
viral vector vaccine
|
|
gptkbp:trialCountries
|
gptkb:Argentina
gptkb:Belgium
gptkb:Brazil
gptkb:Chile
gptkb:Colombia
gptkb:Mexico
gptkb:Peru
gptkb:Philippines
gptkb:South_Africa
gptkb:United_States
|
|
gptkbp:trialParticipants
|
~44,000
|
|
gptkbp:vectorFor
|
gptkb:adenovirus_serotype_26
|
|
gptkbp:WHOEmergencyUseListing
|
2021-03-12
|
|
gptkbp:withdrawnOrLimitedUse
|
United States (2023)
|
|
gptkbp:bfsParent
|
gptkb:Johnson_&_Johnson_COVID-19_vaccine
|
|
gptkbp:bfsLayer
|
5
|